Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
2019-nCoV S1 | monoclonal | Recombinant Human | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
2019-nCoV S1 | monoclonal | Recombinant Mouse | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) NSP1 | monoclonal | Rabbit | SARS-CoV-2 (2019-nCoV) | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike Glycoprotein S2 Subunit Extracellular Domain | D001 | Chimeric | SARS-CoV-2; | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 NSP10 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 NSP3 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 NSP4 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 NSP7 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 NSP8 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 NSP9 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 ORF8 | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 (COVID-19) E protein | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 and SARS-CoV-2 variants of Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Variants (Omicron) NP | monoclonal | Recombinant Rabbit | SARS-CoV, SARS-CoV-2 and SARS-CoV-2 variants of Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 N Protein | OTIH1G5 | Human | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | OTIH3C6 | Human | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2 variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Variants (Omicron) S RBD | monoclonal | Recombinant Human | SARS-CoV-2, SARS-CoV-2 Variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529). | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 Spike Protein (Bebtelovimab biosimilar) | monoclonal | Recombinant Human | n/a | Protein A purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
SARS-CoV-2 N Protein | CR3009 (03-009) | Recombinant Human | SARS-CoV | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | CR3009 (03-009) | Recombinant Human | SARS-CoV | unconjugated | 50 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | CR3009 (03-009) | Recombinant Human | SARS-CoV | unconjugated | 50 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | CR3009 (03-009) | Recombinant Rabbit | SARS-CoV | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | CR3018 (03-018) | Recombinant Human | SARS-CoV | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 N Protein | CR3018 (03-018) | Recombinant Human | SARS-CoV | unconjugated | 50 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |